Matches in Wikidata for { <http://www.wikidata.org/entity/Q64657355> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64657355 description "assaig clínic" @default.
- Q64657355 description "clinical trial" @default.
- Q64657355 description "clinical trial" @default.
- Q64657355 description "clinical trial" @default.
- Q64657355 description "clinical trial" @default.
- Q64657355 description "ensaio clínico" @default.
- Q64657355 description "ensayo clínico" @default.
- Q64657355 description "ensayu clínicu" @default.
- Q64657355 description "essai clinique" @default.
- Q64657355 description "klinisch onderzoek" @default.
- Q64657355 description "клінічне випробування" @default.
- Q64657355 description "կլինիկական փորձարկում" @default.
- Q64657355 name "Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)" @default.
- Q64657355 type Item @default.
- Q64657355 label "Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)" @default.
- Q64657355 prefLabel "Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)" @default.
- Q64657355 P1050 Q64657355-408227D0-B0B4-494D-8CF5-D3698383F8F0 @default.
- Q64657355 P1132 Q64657355-91447E60-0CDF-4B62-8F45-03F5D07EFBA8 @default.
- Q64657355 P1476 Q64657355-E776504E-CADF-4CF1-A6E3-D3C8C5F5FFC4 @default.
- Q64657355 P2899 Q64657355-0EB2F9F3-B2E7-4A90-8082-9AB2F2CBD451 @default.
- Q64657355 P3098 Q64657355-5584100C-0585-4FF5-85EC-AB2E983ADF50 @default.
- Q64657355 P31 Q64657355-C366FBB6-23A3-4668-8C0E-467C9C8BAA89 @default.
- Q64657355 P4135 Q64657355-CC5267CC-FD2E-41C3-8A0F-C6C1DCF0D095 @default.
- Q64657355 P4844 Q64657355-F78EFE24-09B6-47B6-91E8-ACA895A37398 @default.
- Q64657355 P580 Q64657355-5770D7C4-DDF6-4C5C-8701-9D47B0BFADF6 @default.
- Q64657355 P582 Q64657355-94574F55-F62A-4F0F-BC24-331CFD93B835 @default.
- Q64657355 P6099 Q64657355-1B22E1A0-BE8A-4666-A6EE-8C01A187829B @default.
- Q64657355 P8363 Q64657355-C4CAAFD4-CA73-4E22-AEEF-399DA974949F @default.
- Q64657355 P1050 Q12206 @default.
- Q64657355 P1132 "+375" @default.
- Q64657355 P1476 "A 12-Week, Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate the Safety, Tolerability and Efficacy Of Once Daily PF-04971729 And Sitagliptin On Glycemic Control And Body Weight In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin" @default.
- Q64657355 P2899 "+18" @default.
- Q64657355 P3098 "NCT01059825" @default.
- Q64657355 P31 Q30612 @default.
- Q64657355 P4135 "+70" @default.
- Q64657355 P4844 Q19484 @default.
- Q64657355 P580 "2010-02-24T00:00:00Z" @default.
- Q64657355 P582 "2011-01-20T00:00:00Z" @default.
- Q64657355 P6099 Q42824440 @default.
- Q64657355 P8363 Q78089383 @default.